News Focus
News Focus
icon url

ciotera

12/06/15 11:03 PM

#198011 RE: DewDiligence #198008

Re: Venetoclax

Funny, how they are reporting ORR and PR but not CR.
10% CR is a failure. Imbruvica probably has that much. So, it's a success as far as it's approvable based on this study, but how will it compete against Imbruvica?